Accolade Debt To Equity Over Time
| ACCD Stock | USD 3.86 0.11 2.93% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Accolade Performance and Accolade Correlation. Accolade |
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Accolade. If investors know Accolade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Accolade listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.02) | Revenue Per Share 5.706 | Quarterly Revenue Growth 0.098 | Return On Assets (0.07) | Return On Equity (0.19) |
The market value of Accolade is measured differently than its book value, which is the value of Accolade that is recorded on the company's balance sheet. Investors also form their own opinion of Accolade's value that differs from its market value or its book value, called intrinsic value, which is Accolade's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Accolade's market value can be influenced by many factors that don't directly affect Accolade's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Accolade's value and its price as these two are different measures arrived at by different means. Investors typically determine if Accolade is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Accolade's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Debt To Equity Analysis
Compare Accolade and related stocks such as Evolent Health, Simulations Plus, and Privia Health Group Debt To Equity Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EVH | 0.1712 | 0.1712 | 0.1712 | 0.1712 | 0.1712 | 0.1712 | 0.1712 | 0.1201 | 0.1932 | 0.3252 | 0.4798 | 0.3211 | 0.4888 | 0.5683 | 0.6 |
| SLP | 1.5 | 0.0023 | 0.0023 | 0.0023 | 0.0023 | 0.0023 | 0.0023 | 0.0023 | 0.0023 | 0.0023 | 0.0023 | 0.0026 | 0.0026 | 0.0026 | 0.0025 |
| PRVA | 0.7571 | 0.7571 | 0.7571 | 0.7571 | 0.7571 | 0.7571 | 0.7571 | 0.7571 | 0.7571 | 0.3911 | 0.2294 | 0.0763 | 0.006 | 0.0054 | 0.0051 |
| HSTM | 0.1135 | 0.0013 | 0.0013 | 0.0013 | 0.0013 | 0.0013 | 0.0013 | 0.0013 | 0.0013 | 0.0013 | 0.0013 | 0.0013 | 0.0013 | 0.0012 | 0.0012 |
| CERT | 0.8279 | 0.8279 | 0.8279 | 0.8279 | 0.8279 | 0.8279 | 0.8279 | 0.8279 | 0.8279 | 0.8156 | 0.3638 | 0.2829 | 0.2714 | 0.2782 | 0.52 |
| PHR | (0.123) | (0.123) | (0.123) | (0.123) | (0.123) | (0.123) | (0.123) | (0.123) | (0.1328) | 0.2343 | 0.043 | 0.0214 | 0.0115 | 0.0125 | 0.0077 |
| FORA | (0.6558) | (0.6558) | (0.6558) | (0.6558) | (0.6558) | (0.6558) | (0.6558) | (0.6558) | (0.6558) | (0.6558) | 0.9643 | 0.9643 | 1.9308 | 0.9504 | 0.64 |
| HQY | 1.2628 | 1.2628 | 1.2628 | 1.2628 | 1.2628 | 1.2628 | 1.2628 | 1.2628 | 1.2628 | 1.2628 | 0.7797 | 0.5442 | 0.5246 | 0.4346 | 0.78 |
| HCAT | (0.0371) | (0.0371) | (0.0371) | (0.0371) | (0.0371) | (0.0371) | (0.0371) | (0.0371) | (0.0536) | 0.2542 | 0.6216 | 0.3531 | 0.5411 | 0.6306 | 0.66 |
Accolade and related stocks such as Evolent Health, Simulations Plus, and Privia Health Group Debt To Equity description
A measure of a company's financial leverage calculated by dividing its total liabilities by stockholders' equity, indicating the proportion of equity and debt the company is using to finance its assets.My Equities
My Current Equities and Potential Positions
| Accolade | ACCD |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Pennsylvania; U.S.A |
| Exchange | NASDAQ Exchange |
USD 3.86
Check out Accolade Performance and Accolade Correlation. For information on how to trade Accolade Stock refer to our How to Trade Accolade Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Accolade technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.